Intracellular microbial biomolecules

Intracellular microbial biomolecules is a broad, collective term referring to the diverse array of nucleic acids, proteins, and metabolites located within a pathogenic microorganism. These molecules serve as the primary targets for various classes of antimicrobial drugs; for instance, fluoroquinolones target microbial DNA gyrase, while macrolides target the bacterial ribosome to halt protein synthesis. In addition to being pharmacological targets, these biomolecules often function as pathogen-associated molecular patterns (PAMPs) that are recognized by the host's innate immune system via pattern recognition receptors (PRRs) like TLRs and NLRs. Because this term encompasses thousands of distinct molecular entities across bacteria, viruses, fungi, and parasites, it is considered a category rather than a specific therapeutic target. Effective drug development requires focusing on specific, conserved microbial enzymes or structural components that differ significantly from human orthologs to ensure selective toxicity.

Other names

Microbial componentsPathogen-associated molecular patterns (PAMPs)Intracellular microbial targetsMicrobial metabolites

Antimicrobial agents target these biomolecules to inhibit essential life processes such as DNA replication, RNA transcription, or protein translation within the pathogen.